RHUMBLINE ADVISERS

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in NTLA

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$1,751,058

+$560,198 QoQ

Shares Held

136,588

+3.1% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 16% Shared 0% None 84%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. NTLA ranks #96 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	423,140	$188,948,935
2	REGN	Regeneron Pharmaceuticals, Inc.	157,781	$121,907,911
3	INCY	Incyte Corp	693,665	$65,287,749
4	ALNY	Alnylam Pharmaceuticals, Inc.	195,277	$64,611,300
5	INSM	INSMED Inc	272,615	$44,578,004
6	JAZZ	Jazz Pharmaceuticals plc	164,542	$31,106,665
7	EXEL	Exelixis, Inc.	723,931	$31,049,400
8	ROIV	Roivant Sciences Ltd.	1,113,266	$30,837,468

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,751,058	136,588	+3.1%	Shares	Sole	2026-05-12
2025-12-31	$1,190,860	132,465	-16.9%	Shares	Sole	2026-02-13
2025-09-30	$2,754,202	159,479	-2.9%	Shares	Sole	2025-11-06
2025-06-30	$1,540,627	164,246	+4.7%	Shares	Sole	2025-08-12
2025-03-31	$1,115,118	156,838	-5.7%	Shares	Sole	2025-05-29
2024-12-31	$1,938,451	166,248	+2.1%	Shares	Sole	2025-05-29
2024-09-30	$3,344,491	162,749	-7.2%	Shares	Sole	2024-11-12
2024-06-30	$3,923,997	175,335	+5.3%	Shares	Sole	2024-08-01
2024-03-31	$4,581,460	166,538	+1.9%	Shares	Sole	2024-05-09
2023-12-31	$4,980,785	163,358	-0.4%	Shares	Sole	2024-02-08
2023-09-30	$5,185,205	163,985	+1.0%	Shares	Sole	2023-11-09
2023-06-30	$6,622,957	162,407	+9.9%	Shares	Sole	2023-08-08
2023-03-31	$5,508,915	147,811	+2.4%	Shares	Sole	2023-05-11
2022-12-31	$5,033,859	144,278	+12.9%	Shares	Sole	2023-02-14
2022-09-30	$7,153,366	127,830	+6.9%	Shares	Sole	2022-11-10
2022-06-30	$6,188,425	119,560	+21.7%	Shares	Sole	2022-08-11
2022-03-31	$7,139,609	98,247	+2.7%	Shares	Sole	2022-05-12
2021-12-31	$11,306,936	95,627	-3.2%	Shares	Sole	2022-02-10
2021-09-30	$13,251,605	98,782	+0.3%	Shares	Sole	2021-11-12
2021-06-30	$15,942,791	98,467	+1.5%	Shares	Sole	2021-08-05
2021-03-31	$7,786,420	97,021	-4.9%	Shares	Sole	2021-05-06
2020-12-31	$5,550,758	102,036	+4.2%	Shares	Sole	2021-02-10
2020-09-30	$1,946,788	97,927	+6.7%	Shares	Sole	2020-11-12
2020-06-30	$1,928,353	91,739	+21.3%	Shares	Sole	2020-08-13
2020-03-31	$924,979	75,632	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.